Nilufer Eldes Hacifazlioglu

Dr. Nilufer Eldes Hacifazlioglu


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 June 2026 in Journal of Pediatric Urology
Verified
Journal Article
Closed access
MÇMuhammed Hamidullah Çakmak
Muhammed Hamidullah Çakmak
FÖFatma Duygu Öztürk Önsal
Fatma Duygu Öztürk Önsal
VSVEFA SALT
VEFA SALT
EUEmek Uyur
Emek Uyur
NHNilufer Eldes Hacifazlioglu
Nilufer Eldes Hacifazlioglu
SMSerdar Moralıoğlu
Serdar Moralıoğlu

1 January 2025 in Archives of Neuropsychiatry
Verified
Journal Article
Closed access
NHNilufer Eldes Hacifazlioglu
Nilufer Eldes Hacifazlioglu
EUEmek Uyur
Emek Uyur
DGDerya Güder
Derya Güder
KGKutlay Gür
Kutlay Gür
OÜOlcay Ünver
Olcay Ünver
YYYüksel Yılmaz
Yüksel Yılmaz
Infantile Epileptic Spasms Syndrome (IESS) is an age-related developmental and epileptic encephalopathy that may be resistant to treatment and can negatively affect neurodevelopment. The classification of the etiology of IESS is important for its treatment, considering prognosis, and for future studies. The present study aimed to investigate the difficulties in etiologic classification of IESS based on the International League Against Epilepsy (ILAE, 2017). The data of patients diagnosed with IESS between 2014 and 2023 were reviewed retrospectively. The diagnosis of IESS was made by the presence of epileptic spasm and/or hypsarrhythmia on electroencephalography (EEG). Etiological classification was made based on the 2017 (ILAE) etiologic classification and the difficulties encountered were examined. In this study, 108 patients, 63 (%58) girls and (%42)45 boys, with a mean age of 22±13 (3-72) months, were included. The etiology remained unclear in 30 patients (27.7%) and was detected in 78 patients (72.2%). The underlying causes of patients were genetic 16 (14.8%), structural 57 (61.5%), inherited metabolic diseases 4 (3.7%), and infectious 1 (0.9%). Congenital metabolic diseases were included in the metabolic diseases group. Since different etiologies could cause IESS, either alone or in combination, difficulties were encountered especially in grouping the patients with a genetic origin of the disease, resulting in structural anomalies and inherited metabolic diseases. The basic difficulty encountered during the ILAE classification of this large group of patients was to classify the genetic causes that result in structural anomalies and congenital metabolic diseases. Previous experience, along with the findings of the present study, suggest that ILAE 2017 etiologic classification may be revised, genetic reasons resulting in structural and/or metabolic abnormalities should be classified under the name of genetic origin and that genetic titles should be divided into subgroups such as genetic metabolic, genetic structural, and other genetic categories.